Public Sector Pension Investment Board Buys 5,865 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Public Sector Pension Investment Board boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 159,223 shares of the medical equipment provider’s stock after acquiring an additional 5,865 shares during the quarter. Public Sector Pension Investment Board’s holdings in Intuitive Surgical were worth $70,830,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in Intuitive Surgical by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after buying an additional 272,741 shares in the last quarter. Capital World Investors grew its holdings in Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after acquiring an additional 73,634 shares during the last quarter. Edgewood Management LLC increased its position in Intuitive Surgical by 7.9% in the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock valued at $1,731,016,000 after acquiring an additional 374,667 shares in the last quarter. Finally, Jennison Associates LLC raised its stake in shares of Intuitive Surgical by 4.6% in the first quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock worth $1,791,253,000 after acquiring an additional 198,483 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. The Goldman Sachs Group initiated coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.00 price target on the stock. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Citigroup boosted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Finally, Robert W. Baird boosted their price objective on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $486.20 on Monday. The firm has a market capitalization of $172.46 billion, a PE ratio of 87.76, a P/E/G ratio of 5.41 and a beta of 1.39. The stock has a 50 day simple moving average of $468.01 and a 200 day simple moving average of $425.38. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm’s revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Activity

In related news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the sale, the insider now owns 295 shares of the company’s stock, valued at $145,113.45. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.